Providing rational dosage regimens to combat SARS-CoV-2 by translational pharmacology


This series will feature UF investigators funded by the Rapid-Response Translational Research Projects to Address COVID-19 Pandemic pilot program. The goal of this program is to stimulate cross-disciplinary knowledge and research.

Monday, Jun. 1, 2020 | 3:30 p.m.

Providing rational dosage regimens to combat SARS-CoV-2 by translational pharmacology

A close-up image of a COVID-19 testing swab

Speakers

Ashley Brown, PhD

Ashley Brown, PhD

Dr. Brown is an associate professor of medicine with the UF Health Institute for Therapeutic Innovation. She is also the program director of the antiviral pharmacodynamics laboratory in the UF College of Medicine’s department of medicine.

Dr. Brown’s research unit is located at the UF Research and Academic Center at Lake Nona.  


Jürgen Bulitta, PhD

Jürgen Bulitta, PhD

Dr. Bulitta is an associate professor in the Department of Pharmacotherapy and Translational Research at the UF College of Pharmacy. His research focuses on combating multidrug-resistant bacterial ‘superbugs’ which present one of the three most serious threats to human health.

Dr. Bulitta’s research unit is located at the UF Research and Academic Center at Lake Nona